Anne L Angiolillo

Title: The Innovative Contributions of Anne L Angiolillo

Introduction

Anne L Angiolillo is a prominent inventor based in Washington, DC. She has made significant contributions to the field of biomedical research, particularly in the area of angiogenesis. Her work has implications for various medical conditions, including cancer and other diseases characterized by abnormal blood vessel growth.

Latest Patents

Anne L Angiolillo holds a patent for her invention titled "Interferon-inducible protein 10 is a potent inhibitor of angiogenesis." This invention focuses on the use of interferon-inducible protein 10 (IP-10) and its fragments and analogs as inhibitors of angiogenesis. The patent highlights that IP-10 profoundly inhibits basic fibroblast growth factor (bFGF)-induced neovascularization in immunocompromised mammals. Furthermore, it demonstrates that IP-10 is effective in a dose-dependent manner in suppressing endothelial cell differentiation into tubular capillary structures.

Career Highlights

Anne L Angiolillo is associated with the United States of America as represented by the Department of Health. Her work has been instrumental in advancing our understanding of angiogenesis and its regulation. With her innovative research, she has contributed to the development of potential therapeutic strategies for diseases involving abnormal blood vessel formation.

Collaborations

Throughout her career, Anne has collaborated with notable researchers, including Giovanna Tosato and Cecilia Sgadari. These collaborations have further enriched her research and expanded the impact of her inventions in the scientific community.

Conclusion

Anne L Angiolillo's contributions to the field of biomedical research, particularly through her patent on interferon-inducible protein 10, highlight her role as an influential inventor. Her work continues to pave the way for advancements in medical treatments targeting angiogenesis.